Plasma Cell Neoplasms are a family of disorders characterized by clonal proliferation of a plasma cell. These include: Multiple Myeloma (MM) and its precursor states MGUS and SMM, solitary osseous or non-osseous plasmacytoma, POEMS syndrome, heavy chain disease, and systemic AL amyloidosis. The hallmark characteristics of plasma cell neoplasms are: (1) histopathologic confirmation of excess clonal plasma cells; and (2) excessive production and secretion of an intact monoclonal protein (M spike) or free light chains (FLC; not in association with heavy chains) in the serum and/or urines. Plasma cell neoplasms can be premalignant (e.g. MGUS) or malignant (e.g. MM).
Phenotype/cell stem origin

MGUS, SMM, MM
Antigen-selected, post-germinal center, terminally differentiated plasma cell (Anderson and Carrasco 2011) Plasmacytoma Well defined, monoclonal proliferation of plasma cells that occurs either (1) inside (solitary bone plasmacytoma) or (2) outside (extramedullary plasmacytoma) the bone (Chang et al, 2014) .
Heavy chain disease (HCD)
Group of three rare and clinically distinct B-cell neoplasms (alpha, gamma, mu HCD) that result in the excessive production of abnormal immunoglobulin heavy chain incapable of binding light chains (Bianchi et al 2014) . Alpha HCD is associated with immunoproliferative small intestinal disease with features resembling MALT lymphoma. Gamma HCD has features resembling Waldenstrom macroglobulinemia (WM) while Mu HCD has features resembling CLL (Bianchi et al 2014) .
POEMS syndrome
Rare paraneoplastic syndrome caused by underlying plasma cell neoplasm. Characterized by polyradiculoneuropathy, the presence of clonal plasma cells, sclerotic bone lesions, elevated vascular endothelial growth factor, and Castleman disease. Other minor features include: organomegaly, endocrinopathy, characteristic skin changes, papilledema, extravascular volume overload, and thrombocytosis (Dispenzieri A, 2014 
MGUS, SMM, MM
Transformation of normal plasma cells into myeloma cells thought to result from one of two primary genetic events: either (1) hyperdiploidy or (2) aberrant class switch recombination (CSR). Secondary cytogenetic abnormalities result in progression of MGUS to SMM, MM, and plasma cell leukemia (Ho et al, 2017) .
Plasmacytoma
Similar to MM in that cell of origin is plasma cell; expresses antigens associated with myelomonocytes (CD33), megakaryocytes (GpIIb/IIIa), erythroid cells (glycophorin) (Nikhil Sangle, 2011) .
Heavy chain disease
Deletions, insertions or point mutations in the constant 1 (CH1) domain of the IgH are acquired during the process of somatic hypermutation. These mutations typically result in: (1) inability to bind and reach a stable quaternary structure with IgL chain; (2) inability to bind to the chaperone heat shock protein 78 (HSP 78), which mediates proteasomal degradation of free IgH (Goossens et al., 1998 
